Inhibitory effect of HCPT on expression of HIF-1α and downstream genes in hypoxic human cervical SiHa cancer cells

Abstract

The hypoxic model to simulate hypoxic microenvironment in solid tumors was established and the effect of hydrocamptothecin (HCPT) on the hypoxia-induced over-expression of HIF-1α and VEGF genes was explored. Human cervical cancer SiHa cells were cultured in vitro under hypoxic conditions (37°C, 5% CO₂, 1% O₂) and treated with different concentrations of HCPT for 24 h. The mRNA and protein expression levels of HIF-1α, VEGF and Glut1 in SiHa cells were detected by semi-quantitative RT-PCR and Western blot respectively. Normoxic control groups were exposed to normoxic conditions for 24 h. Under normoxic conditions, HCPT had no obvious effects on the HIF-1α and VEGF gene expression. Hypoxia induced the up-regulation of HIF-1α protein and downstream VEGF gene, and HCPT showed a dose-dependently inhibitory effect on the hypoxia-induced over-expression of HIF-1α protein and VEGF gene expression in SiHa cells, whereas HCPT had no significant effect on the HIF-1α mRNA expression. No difference in HCPT cytotoxicity was observed between hypoxic groups and normoxic control groups. It was suggested that HCPT could inhibite the expression of HIF-1α protein and downstream VEGF gene in hypoxic SiHa cells in a dose-dependent manner, and the inhibitory effect was not related with HCPT cytotoxicity.

Keywords

hydrocamptothecin / HIF-1α / VEGF / cervical cancer

References

[1] JiangB. H., AganiF., PassanitiA., et al.. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res, 1997, 57(23): 5328-5335

[2] HoebenA., LanduytB., HighleyM. S., et al.. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev, 2004, 56(4): 549-580

[3] BachtiaryB., SchindlM., PotterR., et al.. Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. Clin Cancer Res, 2003, 9(6): 2234-2240

[4] JubbA. M., PhamT. Q., HanbyA. M., et al.. Expression of vascular endothelial growth factor, hypoxia inducible factor 1α, and carbonic anhydrase IX in human tumors. J Clin Path, 2004, 57: 504-512

[5] BirnerP., SchindlM., ObermairA., et al.. Overpression of hypoxia-inducible 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res, 2000, 60(17): 4693-4696

[6] RapisardaA., UranchimegB., SordetO., et al.. Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications. Cancer Res, 2004, 64(4): 1475-1482

[7] ArshamA. M., PlasD. R., ThompsonC. B., et al.. Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1 alpha nor sufficient for HIF-1-dependent target gene transcription. J Biol Chem, 2002, 277(17): 15 162-15 170

[8] MasoodR., CaiJ., ZhengT., et al.. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor positive human tumors. Blood, 2001, 98(6): 1904-1913

[9] TangjitgamolS., RamirezP. T., SunC. C., et al.. Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study. Int J Gyneol Cancer, 2005, 15(4): 646-656

[10] KandaK., UedaM., FutakuchiM., et al.. Transcriptional expression of the genes implicated in angiogenesis and tumor invasion in cervical carcinomas. Gynecol Oncol, 2005, 98(3): 453-461

[11] TangJ. O., HongS. E.. The prognostic effect of VEGF expression in squamous cell carcinoma of the cervix treated with radiation therapy alone. J Korean Med Sci, 2004, 19(5): 693-697

[12] TranJ., MasterZ., YuJ. L., et al.. A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc Natl Acad Sci, 2002, 99(7): 4349-4354

[13] RapisardaA., UranchimegB., ScudieroD., et al.. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res, 2002, 62: 4316-4324